Adverse Event Reporting definition
Examples of Adverse Event Reporting in a sentence
These include: o Training on the DSHS system for documenting vaccine encounters during the event o Training on the DSHS system for collecting ImmTrac2 consent forms o Training on the DSHS Data Logger you will be issued on the event day by the COVID-19 Vaccine Storage Facility o Training on the Vaccine Adverse Event Reporting System (VAERS) o Training on How to Prepare All Physical Event Paperwork for Submission to the Appropriate Texas Public Health Entity.
During the Exclusive Period, either Party shall promptly report to the other Party any information regarding adverse events related to the use of the Product in accordance with the Adverse Event Reporting Procedures (as may be amended from time to time upon mutual agreement) set forth as Exhibit E and incorporated herein by reference.
Pharmacist must report adverse events to the Vaccine Adverse Event Reporting System (VAERS) within seventy-two (72) hours of the adverse event.
From time to time after the Effective Date, representatives from both Parties shall meet to review and revise or replace such Adverse Event Reporting and pharmacovigilance procedures.
To the extent Trubion has or receives any information regarding any adverse drug experience which may be related to the use of any Licensed Product or to Licensed Product Development, Trubion shall promptly provide Wyeth with all such information in accordance with the Adverse Event Reporting and pharmacovigilance procedures set forth in Exhibit 4.4 attached hereto (as may be amended from time to time upon written mutual agreement of the Parties).
D-1 Exhibit E Adverse Event Reporting Procedures ...................................
The Parties agree to use commercially reasonable efforts to reach agreement on Adverse Event Reporting Procedures which will be set forth in Exhibit D attached hereto (as the same may be amended from time to time by notice in writing from Purchaser to Supplier, the “Adverse Event Reporting Procedures”) at least three (3) months prior to Launch but shall reach such agreement no later than one (1) month prior to Launch.
Each Party shall fully, accurately and promptly provide to the other Party with all data known to it at any time during the term of this Agreement or thereafter, which data indicate that any Product marketed by WCH is or may be unsafe, lacks utility, or otherwise does not meet Specifications in accordance with the Adverse Event Reporting Procedures set forth in Exhibit D attached hereto (as the same may be amended from time to time by notice in writing from WCH to IMPAX).
The process and responsibilities for such reports will be governed by the Adverse Event Reporting Addendum separately agreed to by the Parties.
FDA’s Guidance on Adverse Event Reporting to Institutional Review Boards in Clinical Trials (January 2009) may be used in meeting this requirement The provisions of this Section shall survive for two years after termination of this Agreement.